Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Holter Monitor: 24-Hour Monitoring01:23

Holter Monitor: 24-Hour Monitoring

Holter monitoring is a continuous electrocardiography (ECG) recording that tracks the heart's electrical activity over an extended period, generally 24 to 48 hours. This noninvasive diagnostic tool detects irregular heart rhythms that may not be captured during a standard ECG performed in a clinical setting.DeviceThe Holter monitor is a portable, small device connected to several electrodes on the patient's chest. These electrodes detect the heart's electrical signals and transmit them to the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selection of 3D-Printing Optimal Parameters via MCDM for Maximizing the Thermomechanical Response of TPU and PEEK.

Polymers·2026
Same author

Safety of very low LDL-cholesterol: Ten common concerns, misconceptions, and evidence-based clarifications.

Atherosclerosis·2026
Same author

Structural basis for selective thymidine binding by the Borrelia burgdorferi substrate-binding protein BmpA.

The Journal of biological chemistry·2026
Same author

The molecular basis for nuclear pore destruction by a proximity-inducing molecular glue.

Cell chemical biology·2026
Same author

Progression from Carbapenem-Resistant Enterobacterales Colonization to Bacteremia in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Cohort Study.

Mediterranean journal of hematology and infectious diseases·2026
Same author

Identifying Weekly Physical and Physiological Profiles in Professional Basketball Using Heart Rate Variability and Training Load Clustering.

Research quarterly for exercise and sport·2026

Related Experiment Video

Updated: Jul 16, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

Lasting Empowerment After Discontinuing a Heart Failure Telemonitoring Program: A Randomized Controlled Trial.

Jesús Beltrán1,2,3, Diana Achury2,4, Ángel García-Peña1,2,3

  • 1Cardiology Unit, Hospital Universitario San Ignacio, San Ignacio University Hospital, Bogotá, Colombia.

Computers, Informatics, Nursing : CIN
|July 14, 2026
PubMed
Summary

The ControlVit mobile app did not reduce heart failure (HF) hospitalizations or deaths. However, it significantly improved patient empowerment, showing lasting behavioral effects in chronic HF management.

Keywords:
Cardiovascular rehabilitationHeart failureMobile applications

More Related Videos

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Related Experiment Videos

Last Updated: Jul 16, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Area of Science:

  • Cardiology
  • Digital Health
  • Health Outcomes Research

Background:

  • Chronic heart failure (HF) management requires continuous patient engagement.
  • Mobile health (mHealth) applications offer potential for remote patient monitoring and support.
  • Long-term effects of mHealth interventions after discontinuation are not well understood.

Purpose of the Study:

  • To evaluate the sustained impact of the ControlVit mobile application on clinical outcomes and patient empowerment in chronic HF patients.
  • To assess the effects 6 months after the app's discontinuation.

Main Methods:

  • Open-label, randomized controlled trial involving 140 chronic HF patients.
  • Intervention group received standard HF care plus ControlVit app for 6 months; control group received standard care.
  • Follow-up for 6 months after app discontinuation, totaling 12 months.

Main Results:

  • No significant difference in the composite outcome of death or HF readmission between groups (11.4% vs 4.3%, P=.122).
  • Significantly higher patient empowerment scores in the intervention group (P=.012).
  • Increased use of SGLT2 inhibitors and ARNi in both groups during follow-up.

Conclusions:

  • The ControlVit app did not reduce mortality or HF readmissions post-discontinuation.
  • The intervention demonstrated sustained improvements in patient empowerment, indicating a lasting behavioral impact.
  • Mobile telemonitoring may enhance patient self-management and empowerment in chronic HF care.